| Primary |
| Drug Use For Unknown Indication |
28.7% |
| General Anaesthesia |
9.8% |
| Anxiety |
7.9% |
| Premedication |
6.4% |
| Pruritus |
6.4% |
| Urticaria |
4.5% |
| Insomnia |
3.8% |
| Ill-defined Disorder |
3.4% |
| Agitation |
3.0% |
| Nausea |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Depression |
2.6% |
| Hypersensitivity |
2.6% |
| Anaesthesia |
2.3% |
| Endocarditis Staphylococcal |
2.3% |
| Psoriasis |
2.3% |
| Rash |
2.3% |
| Abscess |
1.9% |
| Epilepsy |
1.9% |
| Prurigo |
1.9% |
|
| Completed Suicide |
15.1% |
| Death |
15.1% |
| Somnolence |
9.7% |
| Suicide Attempt |
7.5% |
| Tachycardia |
6.5% |
| Acute Generalised Exanthematous Pustulosis |
4.3% |
| Urticaria |
4.3% |
| Vomiting |
4.3% |
| Blood Pressure Fluctuation |
3.2% |
| Overdose |
3.2% |
| Pharmaceutical Product Complaint |
3.2% |
| Restless Legs Syndrome |
3.2% |
| Torsade De Pointes |
3.2% |
| Toxic Skin Eruption |
3.2% |
| Weight Decreased |
3.2% |
| Anaphylactic Reaction |
2.2% |
| Coma Scale Abnormal |
2.2% |
| Drug Exposure During Pregnancy |
2.2% |
| Drug Interaction |
2.2% |
| Erythema Multiforme |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
26.8% |
| Drug Use For Unknown Indication |
17.0% |
| Anxiety |
5.3% |
| Anaesthesia |
4.6% |
| Hypertension |
4.3% |
| Pain |
4.3% |
| Urticaria |
4.1% |
| Insomnia |
3.8% |
| Pyrexia |
3.3% |
| Constipation |
3.0% |
| Infection |
3.0% |
| Pruritus |
3.0% |
| Sedation |
3.0% |
| Agitation |
2.5% |
| Depression |
2.5% |
| Multiple Drug Overdose |
2.3% |
| Ill-defined Disorder |
2.0% |
| Rash |
1.8% |
| Sciatica |
1.8% |
| Bipolar Disorder |
1.5% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
15.0% |
| Death |
11.3% |
| Vomiting |
11.3% |
| Completed Suicide |
8.8% |
| Thrombocytopenia |
6.3% |
| Toxicity To Various Agents |
5.0% |
| Accidental Overdose |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Hypertension |
3.8% |
| Somnolence |
3.8% |
| Urticaria |
3.8% |
| Weight Decreased |
3.8% |
| Drug Dispensing Error |
2.5% |
| Drug Eruption |
2.5% |
| Drug Interaction |
2.5% |
| Drug Screen False Positive |
2.5% |
| Neuroleptic Malignant Syndrome |
2.5% |
| Overdose |
2.5% |
| Pruritus |
2.5% |
| Rash |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.6% |
| Drug Use For Unknown Indication |
12.4% |
| Anxiety |
4.3% |
| Depression |
4.3% |
| Hypertension |
4.3% |
| Prophylaxis |
4.0% |
| Pain |
3.9% |
| Hiv Infection |
2.9% |
| Hepatitis C |
2.8% |
| Pruritus |
2.5% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Sleep Disorder |
2.3% |
| Acute Myeloid Leukaemia |
2.0% |
| Psoriasis |
2.0% |
| Infection Prophylaxis |
1.9% |
| Premedication |
1.9% |
| Insomnia |
1.8% |
| Diabetes Mellitus |
1.7% |
| Nausea |
1.6% |
| Bipolar Disorder |
1.5% |
|
| Vomiting |
16.1% |
| Type 2 Diabetes Mellitus |
11.1% |
| Pulmonary Embolism |
7.8% |
| Rash |
7.8% |
| Deep Vein Thrombosis |
5.1% |
| Dyspnoea |
5.1% |
| Pruritus |
4.6% |
| Weight Increased |
4.6% |
| White Blood Cell Count Decreased |
4.1% |
| Death |
3.7% |
| Pneumonia |
3.7% |
| Pain |
3.2% |
| Psoriasis |
3.2% |
| Urticaria |
3.2% |
| Weight Decreased |
3.2% |
| Nausea |
2.8% |
| Oedema Peripheral |
2.8% |
| Walking Disability |
2.8% |
| Wheezing |
2.8% |
| Hospitalisation |
2.3% |
|
| Interacting |
| Migraine |
20.0% |
| Product Used For Unknown Indication |
20.0% |
| Anxiety |
13.3% |
| Hypertension |
13.3% |
| Major Depression |
13.3% |
| Blood Cholesterol Abnormal |
6.7% |
| Fluid Retention |
6.7% |
| Heart Rate Irregular |
6.7% |
|
| Dizziness |
25.0% |
| Drug Diversion |
25.0% |
| Nervousness |
25.0% |
| Somnolence |
25.0% |
|
